Allianz Asset Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
Allianz Asset Management's TWST Position: Q2 2026 in Review
Allianz Asset Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 12,900 shares worth $1.33M. The stake represents ﹤0.01% of the portfolio and ranks #1830 among its holdings. This is a return to the name: Allianz Asset Management previously reported a position in TWST as recently as Q1 2025.
Allianz Asset Management first reported a position in TWST in Q3 2019 and has held it in 17 quarters since. The position peaked at $220M in Q2 2021. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Allianz Asset Management held 12,900 shares of Twist Bioscience worth $1.33M as of Q2 2026.
- Twist Bioscience was a new Allianz Asset Management position in Q2 2026.
- Twist Bioscience made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1830 holding.
- Allianz Asset Management first reported a position in Twist Bioscience in Q3 2019 and has held it in 17 quarters since.
- Allianz Asset Management's Twist Bioscience position peaked at $220M in Q2 2021.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.